Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 3 Effect of berberine on liver glutathione, catalase and superoxide dismutase in male mice infected with S. mansoni

From: Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice

Experimental groups

GSH

CAT

SOD

(mmol/g liver)

(U/g liver)

(U/g liver)

Control

0.8 ± 0.02

1.3 ± 0.04

1455 ± 8.5

PZQ

1.1 ± 0.02a

1.4 ± 0.04

1371 ± 1.4a

BER

1.2 ± 0.02a

1.6 ± 0.01a

1589 ± 6.2ab

Infected

0.61 ± 0.02a

0.75 ± 0.02a

859 ± 1.3a

Infected + PZQ

0.76 ± 0.08ab

1.3 ± 0.01bc

902 ± 2.2abc

Infected + BER

0.67 ± 0.02ab

1.2 ± 0.03bc

924 ± 1.7abc

  1. Values are means ± SD (n = 8). aSignificant difference as compared with Group I (p ≤ 0.05). bSignificant difference as compared with corresponding control group (p ≤ 0.05). cSignificant difference as compared with infected group (Group IV) (p ≤ 0.05).